Cas:16878-50-5 (2-chloro-1,1,1,3,3,3-hexafluoropropan-2-yl)benzene manufacturer & supplier

We serve Chemical Name:(2-chloro-1,1,1,3,3,3-hexafluoropropan-2-yl)benzene CAS:16878-50-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2-chloro-1,1,1,3,3,3-hexafluoropropan-2-yl)benzene

Chemical Name:(2-chloro-1,1,1,3,3,3-hexafluoropropan-2-yl)benzene
CAS.NO:16878-50-5
Synonyms:[2,2,2-trifluoro-2-chloro-1-(trifluoromethyl)ethyl]benzene;PC8035;(2-Chlor-hexafluor-2-propyl)-benzol;MFCD00514599;2-chlorohexafluoro-2-phenylpropane
Molecular Formula:C9H5ClF6
Molecular Weight:262.57900
HS Code:2903999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:144ºC at 760mmHg
Density:1.428g/cm3
Index of Refraction:1.412
PSA:
Exact Mass:261.99800
LogP:4.24530

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like [2,2,2-trifluoro-2-chloro-1-(trifluoromethyl)ethyl]benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-chlorohexafluoro-2-phenylpropane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,PC8035 Use and application,2-chlorohexafluoro-2-phenylpropane technical grade,usp/ep/jp grade.


Related News: In the trial, 362 eligible patients were randomised (1:1) and received a fixed-dose intravenous infusion of 300mg anifrolumab or placebo every four weeks. methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate manufacturers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. 1H-indole-6-carboxylic acid suppliers In taking control of Vanamali, Wavelength will double the firm’s production capacity and add more than 10 key regulatory starting materials and drug intermediates for Wavelength’s own strategic APIs and API CDMO customers, a Wavelength spokeswoman said by email. 2-,6-Di-tert-butyl-N-N-dimethylamino-p-cresol vendor & factory.